Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FM8HJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,849
Award facts
- Contract value 100% obligated
- $6,848.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. The delivery order, valued at $6,848.92 with a firm fixed price arrangement, is scheduled for completion by September 9, 2025, and was issued on August 18, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace. The contract falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.9 billion and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to military health facilities nationwide. The company's expertise in providing specialized pharmaceutical products, including auto-injectors and injection-based medications, positions it as a key vendor for medical supply needs across DoD healthcare systems. The delivery of Xolair, a branded biologic therapy, reflects the company's capability to source and distribute complex pharmaceutical products required by federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FM8HJ?
SPE2DB25FM8HJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FM8HJ worth?
The government has obligated $6,849 on SPE2DB25FM8HJ.
Is contract SPE2DB25FM8HJ an order under another contract?
Yes. SPE2DB25FM8HJ is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB25FM8HJ competed?
The extent of competition for SPE2DB25FM8HJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award